Fundraising FoxGreg Parekh
InvestorFounder & Managing Partner at New Rhein Healthcare Investors, LLC · Board director at Alveus Therapeutics · Board director at Neuraptive Therapeutics
Brussels, Belgium
Find your path to Greg
22 people in our graph can introduce you to Greg.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Ivan Gergel to introduce you to Greg
You →Ivan · together at New Rhein Healthcare Investors, LLC →Greg
Ask Jamie Chen to introduce you to Greg
You →Jamie · 11 people · together at New Rhein Healthcare Investors, LLC →Greg
Sign up to find every way you can get introduced to Greg
- Your email: the people you already email who know Greg
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Greg
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Nayan Gregory Parekh founded New Rhein Healthcare Investors in 2011 and serves as its Managing Partner. He previously ran M&A for Novartis AG in Basel (2004-2010), led Deutsche Bank's European Healthcare Group in London (1998-2004), and began his career at Bear Stearns' Life Sciences group in New York. He holds a Ph.D. in Economics from Northwestern University and a B.A. in Economics and Political Science from the University of Rochester.
Contact· self-published, not guessed
Invests in
BiotechDigital HealthHealthtechMedical Devices
Board director at Alveus Therapeutics
Intro paths
In turn, Greg can intro founders to Alveus Therapeutics's investors below.
Alveus Therapeutics's investors · 9
Board director at Neuraptive Therapeutics
Intro paths
In turn, Greg can intro founders to Neuraptive Therapeutics's investors below.
Neuraptive Therapeutics's investors · 2
Deals · 1
Neuraptive TherapeuticsBoard seat
via New Rhein Healthcare Investors, LLC · filed Oct 2022 · $38.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Alveus Inc.Biocartis NVButterfly Medical Ltd.Chase Pharmaceuticals Inc.Novagali Pharma, SASofthale NV
Per the firm's website.
Colleagues at New Rhein Healthcare Investors, LLC
Frequently asked questions
- Who is Greg Parekh?
- Nayan Gregory Parekh founded New Rhein Healthcare Investors in 2011 and serves as its Managing Partner. He previously ran M&A for Novartis AG in Basel (2004-2010), led Deutsche Bank's European Healthcare Group in London (1998-2004), and began his career at Bear Stearns' Life Sciences group in New York. He holds a Ph.D. in Economics from Northwestern University and a B.A. in Economics and Political Science from the University of Rochester.
- Where does Greg Parekh work?
- Greg Parekh is Founder & Managing Partner at New Rhein Healthcare Investors, LLC and Board director at Alveus Therapeutics and Board director at Neuraptive Therapeutics.
- What does Greg Parekh invest in?
- Greg Parekh invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What boards does Greg Parekh sit on?
- Greg Parekh holds tracked board seats at Alveus Inc., Biocartis NV, Butterfly Medical Ltd., Chase Pharmaceuticals Inc., Neuraptive Therapeutics, Novagali Pharma, SA, Softhale NV.